Role of probiotics in short bowel syndrome in infants and children-A systematic review

Nutrients

Volumn 5, Issue 3, 2013, Pages 679-699

  Reddy, Vudum S ^a   Patole, Sanjay K ^a,b   Rao, Shripada ^b,c  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Children; Infants; Probiotics; Review; Short bowel syndrome

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; PLACEBO; PREALBUMIN; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID;

BACTEREMIA; BACTERIAL OVERGROWTH; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM INFANTIS; BODY HEIGHT; CASE CONTROL STUDY; CASE REPORT; CHILD; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERIC FEEDING; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOLITIS; FECES MICROFLORA; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTIC ACIDOSIS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BULGARICUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LYMPHOCYTE COUNT; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SHORT BOWEL SYNDROME; SYSTEMATIC REVIEW; WEIGHT GAIN;

EID: 84874868839     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu5030679     Document Type: Review

References (89)

1. Goulet, O.; Ruemmele, F. Causes and management of intestinal failure in children. Gastroenterology 2006, 130, S16-S28.
2. O'Keefe, S.J.; Buchman, A.L.; Fishbein, T.M.; Jeejeebhoy, K.N.; Jeppesen, P.B.; Shaffer, J. Short bowel syndrome and intestinal failure: Consensus definitions and overview. Clin. Gastroenterol. Hepatol. 2006, 4, 6-10.
3. Diamanti, A.; Basso, M.S.; Castro, M.; Di Ciommo, V.; Bracci, F.; Ferretti, F.; Pietrobattista, A.; Gambarara, M. Irreversible intestinal failure: Prevalence and prognostic factors. J. Pediatr. Gastroenterol. Nutr. 2008, 47, 450-457.
4. Grant, D. Intestinal transplantation: 1997 report of the international registry. Transplantation 1999, 67, 1061-1064.
5. Spencer, A.U.; Kovacevich, D.; McKinney-Barnett, M.; Hair, D.; Canham, J.; Maksym, C.; Teitelbaum, D.H. Pediatric short-bowel syndrome: The cost of comprehensive care. Am. J. Clin. Nutr. 2008, 88, 1552-1559.
6. Wales, P.W.; de Silva, N.; Kim, J.H.; Lecce, L.; Sandhu, A.; Moore, A.M. Neonatal short bowel syndrome: A cohort study. J. Pediatr. Surg. 2005, 40, 755-762.
7. Spencer, A.U.; Neaga, A.; West, B.; Safran, J.; Brown, P.; Btaiche, I.; Kuzma-O'Reilly, B.; Teitelbaum, D.H. Pediatric short bowel syndrome: Redefining predictors of success. Ann. Surg. 2005, 242, 403-409; discussion 409-412.
8. Wales, P.W.; Christison-Lagay, E.R. Short bowel syndrome: Epidemiology and etiology. Semin. Pediatr. Surg. 2010, 19, 3-9.
9. Salvia, G.; Guarino, A.; Terrin, G.; Cascioli, C.; Paludetto, R.; Indrio, F.; Lega, L.; Fanaro, S.; Stronati, M.; Corvaglia, L.; et al. Neonatal onset intestinal failure: An Italian multicenter study. J. Pediatr. 2008, 153, 674-676.
10. Cole, C.R.; Hansen, N.I.; Higgins, R.D.; Ziegler, T.R.; Stoll, B.J. Very low birth weight preterm infants with surgical short bowel syndrome: Incidence, morbidity and mortality, and growth outcomes at 18 to 22 months. Pediatrics 2008, 122, e573-e582.
11. Wales, P.W.; de Silva, N.; Kim, J.; Lecce, L.; To, T.; Moore, A. Neonatal short bowel syndrome: Population-based estimates of incidence and mortality rates. J. Pediatr. Surg. 2004, 39, 690-695.
12. Martinez, M.; Fabeiro, M.; Dalieri, M.; Barcellandi, P.; Prozzi, M.; Hernandez, J.; Alberti, M.; Fernandez, A., Outcome and survival of pediatric short bowel syndrome (SBS). Nutr. Hosp. 2011, 26, 239-242.
13. Cole, C.R.; Frem, J.C.; Schmotzer, B.; Gewirtz, A.T.; Meddings, J.B.; Gold, B.D.; Ziegler, T.R. The rate of bloodstream infection is high in infants with short bowel syndrome: Relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses. J. Pediatr. 2010, 156, 941-947.
14. Olieman, J.F.; Poley, M.J.; Gischler, S.J.; Penning, C.; Escher, J.C.; van den Hoonaard, T.L.; van Goudoever, J.B.; Bax, N.M.; Tibboel, D.; IJsselstijn, H. Interdisciplinary management of infantile short bowel syndrome: Resource consumption, growth, and nutrition. J. Pediatr. Surg. 2010, 45, 490-498.
15. Sukhotnik, I.; Siplovich, L.; Shiloni, E.; Mor-Vaknin, N.; Harmon, C.M.; Coran, A.G. Intestinal adaptation in short-bowel syndrome in infants and children: A collective review. Pediatr. Surg. Int. 2002, 18, 258-263.
16. Weale, A.R.; Edwards, A.G.; Bailey, M.; Lear, P.A. Intestinal adaptation after massive intestinal resection. Postgrad. Med. J. 2005, 81, 178-184.
17. Cole, C.R.; Ziegler, T.R. Small bowel bacterial overgrowth: A negative factor in gut adaptation in pediatric SBS. Curr. Gastroenterol. Rep. 2007, 9, 456-462.
18. Serrano, M.S.; Schmidt-Sommerfeld, E. Nutrition support of infants with short bowel syndrome. Nutrition 2002, 18, 966-970.
19. Kaufman, S.S.; Loseke, C.A.; Lupo, J.V.; Young, R.J.; Murray, N.D.; Pinch, L.W.; Vanderhoof, J.A. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J. Pediatr. 1997, 131, 356-361.
20. D'Antiga, L.; Dhawan, A.; Davenport, M.; Mieli-Vergani, G.; Bjarnason, I. Intestinal absorption and permeability in paediatric short-bowel syndrome: A pilot study. J. Pediatr. Gastroenterol. Nutr. 1999, 29, 588-593.
21. Kurkchubasche, A.G.; Smith, S.D.; Rowe, M.I. Catheter sepsis in short-bowel syndrome. Arch. Surg. 1992, 127, 21-24; discussion 24-25.
22. Terra, R.M.; Plopper, C.; Waitzberg, D.L.; Cukier, C.; Santoro, S.; Martins, J.R.; Song, R.J.; Gama-Rodrigues, J. Remaining small bowel length: Association with catheter sepsis in patients receiving home total parenteral nutrition: Evidence of bacterial translocation. World J. Surg. 2000, 24, 1537-1541.
23. Kelly, D.A. Intestinal failure-associated liver disease: What do we know today? Gastroenterology 2006, 130, S70-S77.
24. Sondheimer, J.M.; Asturias, E.; Cadnapaphornchai, M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J. Pediatr. Gastroenterol. Nutr. 1998, 27, 131-137.
25. Carter, B.A.; Shulman, R.J. Mechanisms of disease: Update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2007, 4, 277-287.
26. Kelly, D.A. Preventing parenteral nutrition liver disease. Early Hum. Dev. 2010, 86, 683-687.
27. Shanahan, F. The host-microbe interface within the gut. Best Pract. Res. Clin. Gastroenterol. 2002, 16, 915-931.
28. Hooper, L.V.; Gordon, J.I. Commensal host-bacterial relationships in the gut. Science 2001, 292, 1115-1118.
29. Hooper, L.V. Bacterial contributions to mammalian gut development. Trends Microbiol. 2004, 12, 129-134.
30. Barc, M.C.; Charrin-Sarnel, C.; Rochet, V.; Bourlioux, F.; Sandre, C.; Boureau, H.; Dore, J.; Collignon, A. Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii. Anaerobe 2008, 14, 229-233.
31. Koruda, M.J.; Rolandelli, R.H.; Settle, R.G.; Zimmaro, D.M.; Rombeau, J.L. Effect of parenteral nutrition supplemented with short-chain fatty acids on adaptation to massive small bowel resection. Gastroenterology 1988, 95, 715-720.
32. Tappenden, K.A.; Thomson, A.B.; Wild, G.E.; McBurney, M.I. Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology 1997, 112, 792-802.
33. Tappenden, K.A.; McBurney, M.I. Systemic short-chain fatty acids rapidly alter gastrointestinal structure, function, and expression of early response genes. Dig. Dis. Sci. 1998, 43, 1526-1536.
34. Bartholome, A.L.; Albin, D.M.; Baker, D.H.; Holst, J.J.; Tappenden, K.A. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J. Parenter. Enteral. Nutr. 2004, 28, 210-222; discussion 222-223.
35. Yan, F.; Cao, H.; Cover, T.L.; Whitehead, R.; Washington, M.K.; Polk, D.B. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007, 132, 562-575.
36. Fasano, A.; Nataro, J.P. Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins. Adv. Drug Deliv. Rev. 2004, 56, 795-807.
37. Madsen, K.; Cornish, A.; Soper, P.; McKaigney, C.; Jijon, H.; Yachimec, C.; Doyle, J.; Jewell, L.; de Simone, C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121, 580-591.
38. Resta-Lenert, S.; Barrett, K.E. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003, 52, 988-997.
39. Parassol, N.; Freitas, M.; Thoreux, K.; Dalmasso, G.; Bourdet-Sicard, R.; Rampal, P. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res. Microbiol. 2005, 156, 256-262.
40. Otte, J.M.; Podolsky, D.K. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286, G613-G626.
41. Resta-Lenert, S.; Barrett, K.E. Probiotics and commensals reverse TNF-α-and IFN-γ.-induced dysfunction in human intestinal epithelial cells. Gastroenterology 2006, 130, 731-746.
42. Mangell, P.; Nejdfors, P.; Wang, M.; Ahrne, S.; Westrom, B.; Thorlacius, H.; Jeppsson, B. Lactobacillus plantarum 299V inhibits escherichia coli-induced intestinal permeability. Dig. Dis. Sci. 2002, 47, 511-516.
43. Ewaschuk, J.; Endersby, R.; Thiel, D.; Diaz, H.; Backer, J.; Ma, M.; Churchill, T.; Madsen, K. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 2007, 46, 841-850.
44. Sherman, P.M.; Johnson-Henry, K.C.; Yeung, H.P.; Ngo, P.S.; Goulet, J.; Tompkins, T.A. Probiotics reduce enterohemorrhagic Escherichia coli O157:H7-and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect. Immun. 2005, 73, 5183-5188.
45. Lee, Y.K.; Puong, K.Y.; Ouwehand, A.C.; Salminen, S. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J. Med. Microbiol. 2003, 52, 925-930.
46. Patel, R.M.; Myers, L.S.; Kurundkar, A.R.; Maheshwari, A.; Nusrat, A.; Lin, P.W. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am. J. Pathol. 2012, 180, 626-635.
47. Mack, D.R.; Ahrne, S.; Hyde, L.; Wei, S.; Hollingsworth, M.A. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003, 52, 827-833.
48. Caballero-Franco, C.; Keller, K.; de Simone, C.; Chadee, K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G315-G322.
49. Tao, Y.; Drabik, K.A.; Waypa, T.S.; Musch, M.W.; Alverdy, J.C.; Schneewind, O.; Chang, E.B.; Petrof, E.O. Soluble factors from Lactobacillus GG activate mapks and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am. J. Physiol. Cell Physiol. 2006, 290, C1018-C1030.
50. Schlee, M.; Harder, J.; Koten, B.; Stange, E.F.; Wehkamp, J.; Fellermann, K. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin. Exp. Immunol. 2008, 151, 528-535.
51. Fayol-Messaoudi, D.; Berger, C.N.; Coconnier-Polter, M.H.; Lievin-Le Moal, V.; Servin, A.L. Ph-, lactic acid-, and non-lactic acid-dependent activities of probiotic lactobacilli against Salmonella enterica serovar typhimurium. Appl. Environ. Microbiol. 2005, 71, 6008-6013.
52. Lievin, V.; Peiffer, I.; Hudault, S.; Rochat, F.; Brassart, D.; Neeser, J.R.; Servin, A.L. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 2000, 47, 646-652.
53. Ogawa, M.; Shimizu, K.; Nomoto, K.; Tanaka, R.; Hamabata, T.; Yamasaki, S.; Takeda, T.; Takeda, Y. Inhibition of in vitro growth of shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid. Int. J. Food Microbiol. 2001, 68, 135-140.
54. Lievin-Le Moal, V.; Servin, A.L. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: Mucins, antimicrobial peptides, and microbiota. Clin. Microbiol. Rev. 2006, 19, 315-337.
55. Szajewska, H.; Ruszczynski, M.; Radzikowski, A. Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trials. J. Pediatr. 2006, 149, 367-372.
56. Yasui, H.; Nagaoka, N.; Mike, A.; Hayakawa, K.; Ohwaki, M. Detection of Bifidobacterium strains that induce large quantities of IGA. Microb. Ecol. Health Dis. 1992, 5, 155-162.
57. Galdeano, C.M.; Perdigon, G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 2006, 13, 219-226.
58. Shu, Q.; Gill, H.S. A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Med. Microbiol. Immunol. 2001, 189, 147-152.
59. Takeda, K.; Suzuki, T.; Shimada, S.I.; Shida, K.; Nanno, M.; Okumura, K. Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin. Exp. Immunol. 2006, 146, 109-115.
60. Zhang, L.; Li, N.; des Robert, C.; Fang, M.; Liboni, K.; McMahon, R.; Caicedo, R.A.; Neu, J. Lactobacillus Rhamnosus GG decreases lipopolysaccharide-induced systemic inflammation in a gastrostomy-fed infant rat model. J. Pediatr. Gastroenterol. Nutr. 2006, 42, 545-552.
61. Rachmilewitz, D.; Katakura, K.; Karmeli, F.; Hayashi, T.; Reinus, C.; Rudensky, B.; Akira, S.; Takeda, K.; Lee, J.; Takabayashi, K.; et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126, 520-528.
62. Segawa, S.; Wakita, Y.; Hirata, H.; Watari, J. Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice. Int. J. Food Microbiol. 2008, 128, 371-377.
63. Eizaguirre, I.; Urkia, N.G.; Asensio, A.B.; Zubillaga, I.; Zubillaga, P.; Vidales, C.; Garcia-Arenzana, J.M.; Aldazabal, P. Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. J. Pediatr. Surg. 2002, 37, 699-702.
64. Garcia-Urkia, N.; Asensio, A.B.; Zubillaga Azpiroz, I.; Zubillaga Huici, P.; Vidales, C.; Garcia-Arenzana, J.M.; Aldazabal, P.; Eizaguirre, I. Beneficial effects of Bifidobacterium lactis in the prevention of bacterial translocation in experimental short bowel syndrome. Cir. Pediatr. 2002, 15, 162-165.
65. Mogilner, J.G.; Srugo, I.; Lurie, M.; Shaoul, R.; Coran, A.G.; Shiloni, E.; Sukhotnik, I. Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat. J. Pediatr. Surg. 2007, 42, 1365-1371.
66. Eizaguirre, I.; Garcia Urkia, N.; Asensio, A.B.; Hijona, E.; Garcia Arenzana, J.M.; Bachiller, P.; Aldazabal, P. Adaptation in the small intestine: Effect of minimal enteral nutrition and probiotics on proliferation and apoptosis in the intestinal wall. Cir. Pediatr. 2010, 23, 118-121.
67. Tolga Muftuoglu, M.A.; Civak, T.; Cetin, S.; Civak, L.; Gungor, O.; Saglam, A. Effects of probiotics on experimental short-bowel syndrome. Am. J. Surg. 2011, 202, 461-468.
68. Eizaguirre, I.; Aldazabal, P.; Urkia, N.G.; Asensio, A.; Arenzxana, J.M. Escherichia coli translocation in experimental short bowel syndrome: Probiotic supplementation and detection by polymerase chain reaction. Pediatr. Surg. Int. 2011, 27, 1301-1305.
69. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 (updated March 2011); Higgins, J.P.T., Green, S., Eds.; The Cochrane Collaboration, 2011. Available online: http://www.cochrane-handbook.org (accessed on 5 February 2013).
70. ClinicalTrials Web site. Available online: http://www.clinicaltrials.gov/ (accessed on 5 February 2013).
71. Uchida, K.; Takahashi, T.; Inoue, M.; Morotomi, M.; Otake, K.; Nakazawa, M.; Tsukamoto, Y.; Miki, C.; Kusunoki, M. Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr. Surg. Int. 2007, 23, 243-248.
72. Vanderhoof, J.A.; Young, R.J.; Murray, N.; Kaufman, S.S. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 1998, 27, 155-160.
73. Kanamori, Y.; Hashizume, K.; Sugiyama, M.; Morotomi, M.; Yuki, N. Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: A novel synbiotics therapy for intestinal failure. Dig. Dis. Sci. 2001, 46, 2010-2016.
74. Kanamori, Y.; Sugiyama, M.; Hashizume, K.; Yuki, N.; Morotomi, M.; Tanaka, R. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J. Pediatr. Surg. 2004, 39, 1686-1692.
75. Shiau, S.L.; Su, B.H.; Lin, K.J.; Lin, H.C.; Lin, J.N. Possible effect of probiotics and breast milk in short bowel syndrome: Report of one case. Acta Paediatr. Taiwan 2007, 48, 89-92.
76. Candy, D.C.; Densham, L.; Lamont, L.S.; Greig, M.; Lewis, J.; Bennett, H.; Griffiths, M. Effect of administration of Lactobacillus casei Shirota on sodium balance in an infant with short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 2001, 32, 506-508.
77. Sentongo, T.A.; Cohran, V.; Korff, S.; Sullivan, C.; Iyer, K.; Zheng, X. Intestinal permeability and effects of Lactobacillus Rhamnosus therapy in children with short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 2008, 46, 41-47.
78. Kunz, A.N.; Noel, J.M.; Fairchok, M.P. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J. Pediatr. Gastroenterol. Nutr. 2004, 38, 457-458.
79. de Groote, M.A.; Frank, D.N.; Dowell, E.; Glode, M.P.; Pace, N.R. Lactobacillus Rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr. Infect. Dis. J. 2005, 24, 278-280.
80. Munakata, S.; Arakawa, C.; Kohira, R.; Fujita, Y.; Fuchigami, T.; Mugishima, H. A case of D-lactic acid encephalopathy associated with use of probiotics. Brain Dev. 2010, 32, 691-694.
81. Ku, W.H.; Lau, D.C.; Huen, K.F. Probiotics provoked D-lactic acidosis in short bowel syndrome: Case report and literature review. Hong Kong J. Paediatr. 2006, 11, 246-254.
82. Land, M.H.; Rouster-Stevens, K.; Woods, C.R.; Cannon, M.L.; Cnota, J.; Shetty, A.K. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005, 115, 178-181.
83. Apostolou, E.; Kirjavainen, P.V.; Saxelin, M.; Rautelin, H.; Valtonen, V.; Salminen, S.J.; Ouwehand, A.C. Good adhesion properties of probiotics: A potential risk for bacteremia? FEMS Immunol. Med. Microbiol. 2001, 31, 35-39.
84. Ohishi, A.; Takahashi, S.; Ito, Y.; Ohishi, Y.; Tsukamoto, K.; Nanba, Y.; Ito, N.; Kakiuchi, S.; Saitoh, A.; Morotomi, M.; et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J. Pediatr. 2010, 156, 679-681.
85. Borriello, S.P.; Hammes, W.P.; Holzapfel, W.; Marteau, P.; Schrezenmeir, J.; Vaara, M.; Valtonen, V. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin. Infect. Dis. 2003, 36, 775-780.
86. Uchida, H.; Yamamoto, H.; Kisaki, Y.; Fujino, J.; Ishimaru, Y.; Ikeda, H. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J. Pediatr. Surg. 2004, 39, 634-636.
87. Boyle, R.J.; Robins-Browne, R.M.; Tang, M.L. Probiotic use in clinical practice: What are the risks? Am. J. Clin. Nutr. 2006, 83, 1256-1264; quiz 1446-1447.
88. Haschke-Becher, E.; Brunser, O.; Cruchet, S.; Gotteland, M.; Haschke, F.; Bachmann, C. Urinary D-lactate excretion in infants receiving Lactobacillus johnsonii with formula. Ann. Nutr. Metab. 2008, 53, 240-244.
89. Taverniti, V.; Guglielmetti, S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: Proposal of paraprobiotic concept). Genes Nutr. 2011, 6, 261-274.